Cargando…

A rapid screening tool for fatigue impact in multiple sclerosis

BACKGROUND: Fatigue is a common complaint in multiple sclerosis (MS) and often interferes with daily functioning. Both clinicians and researchers may need to detect high levels of fatigue impact using a time and effort efficient tool. This study evaluates the psychometric properties of a rapid scree...

Descripción completa

Detalles Bibliográficos
Autores principales: Kos, Daphne, Nagels, Guy, D'Hooghe, Marie B, Duportail, Marijke, Kerckhofs, Eric
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1579227/
https://www.ncbi.nlm.nih.gov/pubmed/16916440
http://dx.doi.org/10.1186/1471-2377-6-27
_version_ 1782130314854793216
author Kos, Daphne
Nagels, Guy
D'Hooghe, Marie B
Duportail, Marijke
Kerckhofs, Eric
author_facet Kos, Daphne
Nagels, Guy
D'Hooghe, Marie B
Duportail, Marijke
Kerckhofs, Eric
author_sort Kos, Daphne
collection PubMed
description BACKGROUND: Fatigue is a common complaint in multiple sclerosis (MS) and often interferes with daily functioning. Both clinicians and researchers may need to detect high levels of fatigue impact using a time and effort efficient tool. This study evaluates the psychometric properties of a rapid screening instrument for fatigue impact in multiple sclerosis. METHODS: Three visual analogue scales (VAS) for assessing the impact of fatigue were developed. Sixty two subjects with definite MS (mean age 52 +/- 10.5 years; 29 women) and 24 healthy controls (mean age 52 +/- 14 years; 13 women) completed all VAS scales (range 0–100), the Fatigue Severity Scale (FSS) (range 7–63), the Modified Fatigue Impact Scale (MFIS) (range 0–84) and the Guy's Neurological Disability Scale (GNDS) (range 0–5). All tests were repeated with an interval of maximum three days. To evaluate the reproducibility, intraclass correlations (ICC) were calculated, based on one-way analysis of variance for repeated measurements. Validity was considered by means of correlation coefficients. ROC analysis was used to determine the accuracy of the VAS scales. RESULTS: The ICC of the VAS scales ranged from 0.68 to 0.69. VAS scales showed low to moderate correlation with FSS, MFIS and GNDS (Kendall's tau 0.23–0.45) and were not related with physical or cognitive performance, or with depression. All VAS scales were able to discriminate between subjects with MS and controls. Twenty five subjects with MS had a Fatigue Severity Scale score of 36 or more and were classified into the "fatigue" group. ROC analysis showed that VAS_1 is most useful to classify subjects in the "fatigue" group. A cut-off value of VAS_1 of 59 displayed 76% sensitivity and 72% specificity. When using the MFIS score of 40 or more to classify the groups, VAS_1 remained the strongest tool, with 81% sensitivity and 77% specificity at a cut-off value of 59. CONCLUSION: The VAS for the impact of fatigue on daily life (VAS_1) is a moderately reliable, though valid and useful tool to screen rapidly for fatigue impact in multiple sclerosis. A cut-off value of 59 satisfactorily classifies individuals having severe fatigue with a high impact on daily life. In clinical practice, a more comprehensive assessment of fatigue and the impact on daily life is recommended.
format Text
id pubmed-1579227
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15792272006-09-28 A rapid screening tool for fatigue impact in multiple sclerosis Kos, Daphne Nagels, Guy D'Hooghe, Marie B Duportail, Marijke Kerckhofs, Eric BMC Neurol Research Article BACKGROUND: Fatigue is a common complaint in multiple sclerosis (MS) and often interferes with daily functioning. Both clinicians and researchers may need to detect high levels of fatigue impact using a time and effort efficient tool. This study evaluates the psychometric properties of a rapid screening instrument for fatigue impact in multiple sclerosis. METHODS: Three visual analogue scales (VAS) for assessing the impact of fatigue were developed. Sixty two subjects with definite MS (mean age 52 +/- 10.5 years; 29 women) and 24 healthy controls (mean age 52 +/- 14 years; 13 women) completed all VAS scales (range 0–100), the Fatigue Severity Scale (FSS) (range 7–63), the Modified Fatigue Impact Scale (MFIS) (range 0–84) and the Guy's Neurological Disability Scale (GNDS) (range 0–5). All tests were repeated with an interval of maximum three days. To evaluate the reproducibility, intraclass correlations (ICC) were calculated, based on one-way analysis of variance for repeated measurements. Validity was considered by means of correlation coefficients. ROC analysis was used to determine the accuracy of the VAS scales. RESULTS: The ICC of the VAS scales ranged from 0.68 to 0.69. VAS scales showed low to moderate correlation with FSS, MFIS and GNDS (Kendall's tau 0.23–0.45) and were not related with physical or cognitive performance, or with depression. All VAS scales were able to discriminate between subjects with MS and controls. Twenty five subjects with MS had a Fatigue Severity Scale score of 36 or more and were classified into the "fatigue" group. ROC analysis showed that VAS_1 is most useful to classify subjects in the "fatigue" group. A cut-off value of VAS_1 of 59 displayed 76% sensitivity and 72% specificity. When using the MFIS score of 40 or more to classify the groups, VAS_1 remained the strongest tool, with 81% sensitivity and 77% specificity at a cut-off value of 59. CONCLUSION: The VAS for the impact of fatigue on daily life (VAS_1) is a moderately reliable, though valid and useful tool to screen rapidly for fatigue impact in multiple sclerosis. A cut-off value of 59 satisfactorily classifies individuals having severe fatigue with a high impact on daily life. In clinical practice, a more comprehensive assessment of fatigue and the impact on daily life is recommended. BioMed Central 2006-08-17 /pmc/articles/PMC1579227/ /pubmed/16916440 http://dx.doi.org/10.1186/1471-2377-6-27 Text en Copyright © 2006 Kos et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kos, Daphne
Nagels, Guy
D'Hooghe, Marie B
Duportail, Marijke
Kerckhofs, Eric
A rapid screening tool for fatigue impact in multiple sclerosis
title A rapid screening tool for fatigue impact in multiple sclerosis
title_full A rapid screening tool for fatigue impact in multiple sclerosis
title_fullStr A rapid screening tool for fatigue impact in multiple sclerosis
title_full_unstemmed A rapid screening tool for fatigue impact in multiple sclerosis
title_short A rapid screening tool for fatigue impact in multiple sclerosis
title_sort rapid screening tool for fatigue impact in multiple sclerosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1579227/
https://www.ncbi.nlm.nih.gov/pubmed/16916440
http://dx.doi.org/10.1186/1471-2377-6-27
work_keys_str_mv AT kosdaphne arapidscreeningtoolforfatigueimpactinmultiplesclerosis
AT nagelsguy arapidscreeningtoolforfatigueimpactinmultiplesclerosis
AT dhooghemarieb arapidscreeningtoolforfatigueimpactinmultiplesclerosis
AT duportailmarijke arapidscreeningtoolforfatigueimpactinmultiplesclerosis
AT kerckhofseric arapidscreeningtoolforfatigueimpactinmultiplesclerosis
AT kosdaphne rapidscreeningtoolforfatigueimpactinmultiplesclerosis
AT nagelsguy rapidscreeningtoolforfatigueimpactinmultiplesclerosis
AT dhooghemarieb rapidscreeningtoolforfatigueimpactinmultiplesclerosis
AT duportailmarijke rapidscreeningtoolforfatigueimpactinmultiplesclerosis
AT kerckhofseric rapidscreeningtoolforfatigueimpactinmultiplesclerosis